… In our review, baseline PRO scores were also reported in majority of trials and particularly
in … have been published including data from the PACIFIC open-label phase III trial exploring …

… of associations between selected PRO scale scores and … from baseline in patient-reported
outcomes and lower risk of … increase in patient-reported outcome scores obtained from …

… , we searched the references of selected papers and consulted … the generalisability of PRO
results to the whole trial population. … Analysis of a randomized phase III trial of the cancer and …

… the phase 3 pediatric trial using Patient-Reported Outcomes … the PRO results from the
phase 3 pediatric trial, specifically … was created by selecting items from the three pediatric item …

… from randomization to the first time a patient’s score showed a … data, compared with the phase
3 ALEX trial (66 % and 64 % … non-small cell lung cancer in the global phase III ALEX study …

… Little improvement into the uptake and assessment of PRO as an outcome in RCTs for BC
… We thus rated each RCT with a score ranging from 0 to a maximum of 18 (RCT with PRO as …

… with stage II–IIIA NSCLC, and select patients with stage IB … HRQoL scores in Chinese patients
with resected stage II–IIIA … treatments and crossover to open-label osimertinib. Finally, the …

… (PROs) can inform treatment selection and assess treatment … ADMIRAL was a phase 3,
open-label, multicenter, randomized … score and two sub-scores that assess fatigue severity across …

… results of a randomized controlled trial (RCT) of PROs in patients with muscle-invasive or
metastatic bladder cancer (BC… Patients were randomized 1:1 between answering selected PRO…

… to assess HRQoL in cancer clinical trials, and its HCC-specific … , which are less prone to
open-label bias. Furthermore, … indicate that open-label bias did not affect these findings. Another …